| Nanosilver mitigates biofilm formation via FapC amyloidosis inhibition Z Huma, I Javed, Z Zhang, H Bilal, Y Sun, SZ Hussain, TP Davis, ... Small 16 (21), 1906674, 2020 | 31 | 2020 |
| Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model H Bilal, AY Peleg, MP McIntosh, IK Styles, EB Hirsch, CB Landersdorfer, ... Journal of Antimicrobial Chemotherapy 73 (6), 1570-1578, 2018 | 25 | 2018 |
| Synergistic meropenem-tobramycin combination dosage regimens against clinical hypermutable Pseudomonas aeruginosa at simulated epithelial lining fluid concentrations in a … H Bilal, PJ Bergen, TH Kim, SE Chung, AY Peleg, A Oliver, RL Nation, ... Antimicrobial Agents and Chemotherapy 63 (11), 10.1128/aac. 01293-19, 2019 | 16 | 2019 |
| Clinically relevant epithelial lining fluid concentrations of meropenem with ciprofloxacin provide synergistic killing and resistance suppression of hypermutable Pseudomonas … H Bilal, PJ Bergen, JR Tait, SC Wallis, AY Peleg, JA Roberts, A Oliver, ... Antimicrobial Agents and Chemotherapy 64 (7), 10.1128/aac. 00469-20, 2020 | 9 | 2020 |
| Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid … JR Tait, H Bilal, TH Kim, A Oh, AY Peleg, JD Boyce, A Oliver, PJ Bergen, ... Journal of Global Antimicrobial Resistance 26, 55-63, 2021 | 7 | 2021 |
| Simulated intravenous versus inhaled tobramycin with or without intravenous ceftazidime evaluated against hypermutable Pseudomonas aeruginosa via a dynamic biofilm model and … H Bilal, JR Tait, Y Lang, J Zhou, PJ Bergen, AY Peleg, JB Bulitta, A Oliver, ... Antimicrobial Agents and Chemotherapy 66 (3), e02203-21, 2022 | 6 | 2022 |
| Identifying a therapeutic target for vancomycin against staphylococci in young infants A Gwee, SB Duffull, AJ Daley, M Lim, S Germano, H Bilal, S Hall, N Curtis, ... Journal of Antimicrobial Chemotherapy 77 (3), 704-710, 2022 | 6 | 2022 |
| Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the … JR Tait, H Bilal, KE Rogers, Y Lang, TH Kim, J Zhou, SC Wallis, JB Bulitta, ... Antibiotics 11 (1), 101, 2022 | 5 | 2022 |
| Susceptibility pattern of Pseudomonas aeruginosa against various antibiotics along with computational analysis H Bilal, F Hasan, S Bilal International Journal of Sciences: Basic and Applied Research 24 (4), 23-45, 2015 | 3 | 2015 |
| Optimising antibiotic administration against difficult-to-treat infections caused by the Gram-negative'superbug'Pseudomonas aeruginosa H Bilal Monash University, 0 | | |
